Cleared Traditional

K101355 - AUGEASE VASCULAR AUGMENTATION DEVICE

K101355 is an FDA 510(k) clearance for AUGEASE VASCULAR AUGMENTATION DEVICE, manufactured by Augdvt, LLC. The device is a Class 2 Cardiovascular device with product code JOW cleared through the Traditional 510(k) pathway after a 165-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2010
Decision
165d
Days
Class 2
Risk

K101355 is an FDA 510(k) clearance for the AUGEASE VASCULAR AUGMENTATION DEVICE. Classified as Sleeve, Limb, Compressible (product code JOW), Class II - Special Controls.

Submitted by Augdvt, LLC (Crofton, US). The FDA issued a Cleared decision on October 26, 2010 after a review of 165 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.5800 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Augdvt, LLC devices

FDA 510(k) Submission Details - K101355

510(k) Number K101355 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 14, 2010
Decision Date October 26, 2010
Days to Decision 165 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
40d slower than avg
Panel avg: 125d · This submission: 165d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JOW Device Classification - Class 2, Special Controls

Product Code JOW Sleeve, Limb, Compressible
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.5800
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - JOW Sleeve, Limb, Compressible

All 148
Devices cleared under the same product code (JOW) and FDA review panel - the closest regulatory comparables to K101355.
PRACTICAL COMPRESSION DEVICE (PCD) 901A&901B
K121962 · Mego Afek AC , Ltd. · Oct 2012
KENDALL SCD 700 SEQUENTIAL COMPRESSION CONTROLLER
K120944 · Covidien · May 2012
VENODYNE V810
K110358 · Microtek Medical, Inc. · May 2011
KENDALL SCD 700 SEQUENTIAL COMPRESSION CONTROLLER
K102737 · Covidien, LLC · Oct 2010
REPROCESSED COMPRESSION SLEEVES
K100909 · Ascent Healthcare Solutions · Jul 2010
LYMPHA PRESS 201MAX, MODEL 201MAX
K100677 · Mego Afek AC , Ltd. · May 2010